Document is current
Any future updates will be listed below
-
Authors
Griffiths, Jason I https://orcid.org/0000-0002-1667-8233
Chi, Feng
Farmaki, Elena
Medina, Eric F
Cosgrove, Patrick A https://orcid.org/0000-0001-7784-7785
Karimi, Kimya L https://orcid.org/0000-0003-0070-2224
Chen, Jinfeng
Grolmusz, Vince K https://orcid.org/0000-0002-5677-895X
Adler, Frederick R
Khan, Qamar J
Nath, Aritro
Chang, Jeffrey T https://orcid.org/0000-0002-4578-5636
Bild, Andrea H https://orcid.org/0000-0003-4850-0453
-
Funding
Funding for this research was provided by:
HHS | NIH | National Cancer Institute (U54CA209978, U01CA264620, P30CA042014)
Cancer Prevention and Research Institute of Texas (RP170668)
Jayne Koskinas Ted Giovanis Foundation for Health and Policy
- License Information
-
More Information
Article History
Received: 10 July 2024
Revised: 24 March 2025
Accepted: 10 April 2025
First Online: 8 May 2025
Disclosure and competing interests statement
: Qamar Khan declares research funding from Novartis. Andrea Bild is a founder of Unravel Genomics, which builds biomarkers of drug response. Aritro Nath is co-founder of Unravel Genomics. The remaining authors declare no competing interests.
